Bremelanotide Acetate Powder

High Standards·Traceability·Scalability

Please feel free to contact Xi'an Sonwu Biotech Co., Ltd. for any products you are interested in.

Send Inquiry Now

Bremelanotide acetate powder (PT 141) is a synthetic cyclic peptide derived from the melanocortin system; its structure is an optimized modification of the naturally occurring alpha-melanocyte-stimulating hormone (α-MSH). The molecule's cyclized structure, which improves conformational stability and allows it to maintain high structural integrity and biological activity under challenging physiological conditions, is made up of a particular amino acid sequence. It has a moderate molecular weight and possesses good hydrophilicity and some degree of conformational selectivity, two physicochemical traits common to functional peptides. The melanocortin receptor family, which is extensively dispersed throughout the central nervous system, is the primary functional partner of PT 141. This peptide exhibits traits associated with neurotransmitter-related pathways, in contrast to conventional regulatory methods that depend on changes in hormone levels. All things considered, PT 141 is a representative functional peptide with a clear structure and good target selectivity, providing substantial utility for studies on receptor interactions and peptide molecular design. If you want to learn more about the peptide bremelanotide acetate supplier, contact Xi'an Sonwu Biotech Co., Ltd.

Xi'an Sonwu Biotech Co., Ltd is a peptide raw material supplier with peptide technology at its core and an international market orientation. Sonwu specialises in the R&D, production, and global supply of functional peptides and polypeptide raw materials. Sonwu's products are widely used across multiple fields, including muscle building, beauty and anti-ageing, hair health, weight management, nootropics, and pharmaceutical raw materials.

Sonwu's products have been widely used in customers' R&D and industrialisation projects worldwide. Based on this, Sonwu has received a lot of feedback on Sonwu's products. Therefore, if you need peptide bremelanotide acetate, please contact Xi'an Sonwu.

Xi'an Sonwu not only provides large-scale production services but can also provide sample packages to customers first.

Xi'an Sonwu not only supplies high-quality bremelanotide acetate powder but also offers customised products according to customer needs.

Firstly, for customised products, customers need to provide information such as the product's CAS number and synthesis route. Sonwu will help you verify whether customisation is possible based on your requirements, or Sonwu will provide professional suggestions.

Secondly, regarding customised packaging, Sonwu's products are available in minimum packaging sizes of 1g, and Sonwu can also provide customised packaging upon customer request.

1. Core physiological regulatory function
PT 141 is a synthetic targeted peptide that acts on the central neuroendocrine system; it modulates sensory perception and helps maintain the stability of endogenous signal transduction rhythms. Within a certain range, the drug can affect sensory sensitivity, supporting conditions such as mental exhaustion and decreased sensory responsiveness, and assisting in the relief of sensory-perceptual imbalances. It also modifies the brain's neurochemical milieu, helping reduce stress associated with stressful situations or irregular sleep-wake cycles. It helps restore mental states harmed by factors like staying up late or emotional swings by balancing sympathetic nervous system activity. The peptide is appropriate for research applications across a wide range of physiological profiles, as its mechanism of action is very mild and reversible, avoiding direct interference with the body's natural rhythms and instead increasing signal transduction efficiency.
2. Benefits of Synergistic Mind-Body Regulation

Bremelanotide acetate has synergistic mind-body effects when compared to traditional hormonal active ingredients. Research suggests it may be able to fully manage both physical sensations and emotions, making it a good candidate for investigation in this area. The drug can affect how emotions are perceived, which can help improve overall comfort, maintain a generally peaceful mind-body state, and reduce mental stress and feelings of exhaustion. Additionally, it usually avoids disrupting basic metabolic and physiological cycles by not directly interfering with endogenous endocrine rhythms or significantly affecting glandular regulatory mechanisms. With a well-defined, balanced metabolic pathway, it generally shows no significant accumulation, offers good overall tolerability, and carries a low risk of dependence; the body can gradually return to its baseline state after use ceases. Its favorable biocompatibility makes it suitable for the ongoing research and development of mild peptide-based applications.

3. Unique Advantages Over Similar Peptides

As an optimized synthetic melanocortin-class peptide, PT 141 offers distinct advantages in physicochemical properties and application performance compared to similar peptide agents, making it suitable for peptide formulation development and related experimental research. First, it exhibits targeted characteristics, acting primarily on specific relevant sites with minimal impact on other receptor systems, thereby demonstrating high overall compatibility. Second, its mechanism of action is relatively gradual, resulting in a progressive response that helps reduce the likelihood of acute discomfort. Additionally, it offers flexibility regarding sample compatibility, allowing use in research models involving diverse age groups and physiological states. With a manageable safety profile, it stands out as a synthetic peptide offering well-balanced overall performance within its class.

1. Receptor Binding and Molecular Mechanism of Action

PT 141 is a synthetic cyclic peptide derivative that targets the melanocortin receptor family, specifically binding to the melanocortin-4 receptor in the central nervous system. Its molecular structure has been optimized; compared to the natural homologous peptide, it exhibits a high degree of complementarity between its spatial configuration and the receptor binding site, demonstrating favorable affinity and binding stability. Upon binding to the receptor, the molecule likely participates in downstream cellular signaling processes and associated signal transduction cascades; the binding process is selective, with relatively limited impact on other receptor subtypes. Due to these molecular binding characteristics, the receptor-bound state is sustained for a period, and the molecule maintains structural stability in physiological fluid environments, functioning as a peptide that mediates biological activity through receptor interaction.

2. Neural Signal Regulation Mechanism

This peptide primarily acts on regions associated with the central nervous system; by binding to specific receptors, it likely participates in the release and transmission of various neurotransmitters. Research indicates a correlation between the peptide and fluctuations in neurotransmitters such as dopamine and norepinephrine; it may influence neural signaling pathways, thereby affecting the overall functional state of the central nervous system. During signal transmission, it modulates the activity levels of distinct neural pathways, influencing conduction rhythms and information exchange to help maintain the overall process in a relatively stable state. Its mode of action is typically gradual, involving no rapid changes in neurotransmitter levels. Furthermore, because the substance primarily participates in endogenous signaling processes, its effects progressively diminish as metabolism proceeds.

3. Mechanism of Endocrine-Linked Regulation

Building upon its central nervous system activity, bremelanotide acetate may further trigger coordinated changes within the body's neuroendocrine network. Alterations in central signaling can be transmitted via neuroendocrine pathways to indirectly influence the activity of certain endocrine glands; this links the drug to changes in the secretory rhythms of endogenous active substances, thereby exhibiting characteristics of systemic, coordinated regulation. This process is primarily indirect-acting not directly on glandular secretion mechanisms but rather manifesting its effects through the body's existing regulatory systems-resulting in a relatively limited impact on endocrine rhythms. The peptide does not interfere with core processes such as basal metabolism or physiological cycles; instead, it primarily participates in neuroendocrine interactions and is gradually metabolized and excreted from the body without showing significant signs of accumulation.

Xi'an Sonwu Biotech Co., Ltd. has established a complete technology platform covering peptide molecular design, custom synthesis, precision purification, structural identification, and quality control. Strictly adhering to international quality management standards, the company ensures its peptide raw materials meet the high-end raw material requirements of overseas customers for purity, stability, and batch consistency.

Looking to the future, Sonwu will continue to deepen peptide technology innovation, expand Sonwu's global cooperation network, and strive to become a trusted, long-term peptide raw material solution partner for international customers.

CERES

HACCP

HALAL

ISO9001

ISO14001

ISO22000

 

In addition to ensuring product quality, another critical priority is guaranteeing smooth delivery for Sonwu's clients. Therefore, Xi'an Sonwu offers a variety of courier options tailored to diverse needs.

1. Through what primary mechanism does bremelanotide acetate exert its biological activity?

It functions via a receptor-mediated signaling pathway. Upon binding its target receptor, the molecule initiates an intracellular signaling cascade that modulates neurotransmitter release, neuronal signaling, and neuroendocrine network activity; the entire process relies on the body's endogenous physiological pathways rather than directly interfering with cellular or glandular functions.

2. What is the primary target of this substance?

Its core target is the melanocortin-4 receptor (MC4R) in the human central nervous system, for which it exhibits high binding selectivity. It specifically binds to this receptor and activates downstream signaling pathways, while showing weak affinity for other melanocortin receptor subtypes. With minimal off-target effects, a clearly defined site of action, and outstanding targeting precision, it possesses key characteristics that distinguish it from other conventional peptide ingredients.

If you are looking for a peptide bremelanotide acetate supplier, contact Xi'an Sonwu. Click the email, and then you get high-quality bremelanotide acetate powder.

Email: sales02@sonwu.com

Hot Tags: bremelanotide acetate powder, China bremelanotide acetate powder manufacturers, suppliers, factory